Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00342810 · ClinicalTrials.gov registry record
Analyses of Existing Framingham Data
A clinical trial, sponsored by National Eye Institute (NEI).
- Completed
- Registry status
- 6,061
- Enrollment target
NCT00342810: Completed study, sponsored by National Eye Institute (NEI).
NCT00342810 is a clinical trial that has completed, run by National Eye Institute (NEI). The registered enrollment target is 6,061 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00342810 has completed, sponsored by National Eye Institute (NEI).
- COMPLETED
- Registry status
- 6,061 participants
- Enrollment target
Study Summary
Since 1948, the Framingham Study has examined a group of men and women every two years for the primary purpose of studying the incidence and prevalence of cardiovascular disease and its risk factors. In 1971 the Framingham Study began a study of the offspring of the original group, including data collection on blood pressure, cigarette smoking, weight, and other factors that are of interest to studies of eye disease. Researchers gave eye exams to some of the original group and to the offspring group. Data from these eye exams have been used to examine risk factors for cataracts, diabetic retinopathy, myopia, and glaucoma. The purpose of this study is to use the previously collected data for continued research on eye-related disorders. No new eye examinations will be conducted. ...
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,061 participants |
| Start Date | 2003-06-25 |
| Est. Completion | 2018-04-25 |
What the finished NCT00342810 record still lists
NCT00342810 is an observational study that tracks outcomes without assigning an intervention. Its 6,061 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00342810 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00342810 about?
NCT00342810 is a clinical study titled "Analyses of Existing Framingham Data". Since 1948, the Framingham Study has examined a group of men and women every two years for the primary purpose of studying the incidence and prevalence of cardiovascular disease and its risk factors. In 1971 the Framingham Study began a study of the offspring of the original group, including data co...
What is the current status of trial NCT00342810?
This trial is currently completed. The enrollment target is 6,061 participants. The study started on 2003-06-25. Estimated completion is 2018-04-25.
Who is sponsoring clinical trial NCT00342810?
This trial is sponsored by National Eye Institute (NEI), which has 221 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07166861 · 6,080 participants · NA
Annual Wellness Visits vs GRACE-augmented Annual Wellness Visits For Older Adults With High Needs - Phase 2
- NCT05884190 · 6,030 participants · NA
Trauma-informed Approach to Timely Detection and Management of Early Postpartum Hypertension
- NCT00005095 · 6,000 participants
Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
- NCT00280202 · 6,000 participants
Detection of Genetic Markers of Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI